Venmax Drugs & Pharmaceuticals Ltd.BSE: VENMAX

Board Meeting Outcome for Revised Outcome Of Board Meeting

· Issued by Venmax Drugs & Pharmaceuticals Ltd. via BSE India

Filed with BSE · · 12 pages · English

The Board, based on the recommendations of the Audit Committee and the Committee of Independent Directors, has considered and approved a Scheme of Merger/Amalgamation among Hatri Pharma Private Limited and Venmax Drugs and Pharmaceuticals Limited (“VDPL” or the “Company” or the “Merger/Amalgamated Company”) and their respective shareholders and creditors (the “Scheme”) under Sections 230 to 232 of

Venmax Drugs & Pharmaceuticals Ltd. on 6ix

Earlier from Venmax Drugs & Pharmaceuticals

Later from Venmax Drugs & Pharmaceuticals

All Venmax Drugs & Pharmaceuticals news releases